What are the causes of schistocytes on a peripheral smear in a young adult and the differential diagnoses?

Causes of Schistocytes on Peripheral Smear in Young Adults

Schistocytes >1% in a young adult should immediately raise suspicion for thrombotic thrombocytopenic purpura (TTP) until proven otherwise, as this is a life-threatening emergency requiring urgent treatment initiation even before confirmatory ADAMTS13 testing returns. 1

Primary Differential Diagnoses

Thrombotic Microangiopathies (TMAs) - Most Critical

TTP (Thrombotic Thrombocytopenic Purpura)

• Immune TTP (iTTP): Autoantibodies against ADAMTS13 - most common in young adults
• Congenital TTP (cTTP): ADAMTS13 gene mutations - can present in adulthood despite being inherited 1, 2
• Schistocyte count typically >1%, often averaging 3.44±1.84% 3
• ADAMTS13 activity <10% is diagnostic 1
• Critical point: Start treatment immediately when suspected; do not wait for ADAMTS13 results 1

Atypical Hemolytic Uremic Syndrome (aHUS)

• Complement-mediated TMA
• Distinguished by more severe renal involvement (creatinine often >2.0-2.25 mg/dL) 1, 4
• ADAMTS13 activity is normal (>10%)
• Schistocytes present with thrombocytopenia and hemolysis 4

Secondary TMAs

• Drug-induced (chemotherapy, immunosuppressants, mTOR inhibitors)
• Pregnancy-associated (HELLP syndrome, preeclampsia) - schistocytes typically <0.5% 5
• Malignancy-associated (metastatic carcinoma) 6
• Infection-related (severe sepsis) 3, 6
• Autoimmune disease-associated (SLE, RA, Sjögren's syndrome) 7

Non-TMA Causes with Lower Schistocyte Counts

Disseminated Intravascular Coagulation (DIC)

• Schistocytes usually <0.5%, rarely reaching 1% 8
• Distinguished by abnormal coagulation profile (elevated PT/PTT, low fibrinogen, elevated D-dimer)
• Acanthocytes often more prominent than schistocytes 8

Mechanical Hemolysis

• Mechanical heart valves: schistocytes typically 0.18% 5
• ECMO/cardiac assist devices 9

Chronic Renal Failure

• Schistocytes typically 0.2%, median 1.35% 6, 5
• Usually accompanied by other RBC morphologic changes 6

Hematologic Conditions

• Megaloblastic anemia: median 1.30% 6
• Hematologic malignancies: median 1.20% 6
• Iron deficiency: correlation with low ferritin 10

Diagnostic Algorithm

Immediate Assessment (Do Not Delay Treatment)

1. Quantify schistocytes using ICSH criteria: Count 1,000 RBCs in optimal smear areas 11, 3

   • >1% = high suspicion for TTP/TMA - initiate treatment immediately
   • <1% = consider other diagnoses but don't exclude TMA

2. Assess for TMA triad:

   • Thrombocytopenia (often <30×10⁹/L in TTP) 1
   • Microangiopathic hemolytic anemia (elevated LDH, low haptoglobin, negative Coombs)
   • Organ dysfunction (neurologic, renal, cardiac)

3. Rule out mimickers immediately:

   • Coagulation profile (normal in TTP, abnormal in DIC) 1
   • Direct Coombs test (negative in TTP) 1
   • Pregnancy test 1

4. Send ADAMTS13 activity STAT (but start treatment before results) 1, 4

Risk Stratification

Calculate PLASMIC score (if time permits):

• Platelet count <30×10⁹/L
• Hemolysis markers present
• No active cancer
• No transplant history
• MCV <90 fL
• INR <1.5
• Creatinine <2.0 mg/dL

Score ≥5 = intermediate-high risk for severe ADAMTS13 deficiency 2

Treatment Initiation Threshold

Start plasma exchange, corticosteroids, and caplacizumab immediately if:

• Schistocytes >1% as main RBC abnormality
• Thrombocytopenia + hemolysis
• Any organ dysfunction (neurologic changes, troponin elevation, renal impairment) 1

Critical Pitfalls to Avoid

1. Waiting for ADAMTS13 results: TTP mortality approaches 90% without treatment; turnaround time can be days 1

2. Dismissing schistocytes <1%: Early TTP may not show prominent schistocytes initially 1, 4

3. Assuming normal creatinine excludes TMA: 58.7% of TTP patients develop AKI; elderly patients have more severe renal involvement 1

4. Missing atypical presentations: Elderly patients (>60 years) present with more delirium/behavioral changes and less profound anemia 1

5. Overlooking autoimmune associations: Young adults with SLE, RA, or Sjögren's have increased TTP risk 7

6. Confusing with DIC: Normal coagulation profile in TTP vs. abnormal in DIC 1, 8

Context-Specific Considerations

In young adults specifically:

• Consider congenital TTP even without childhood history 2
• Pregnancy as trigger in women of childbearing age 1
• Drug exposures (recreational, prescription immunosuppressants)
• Underlying autoimmune disease 7
• Recent infections 3

When schistocytes accompany other RBC changes (poikilocytosis, target cells, etc.), consider non-TMA causes like renal failure, hemoglobinopathy, or hematologic malignancy 3, 6